Debate Con: TAVR for Moderate-Risk Patients: SAVR Remains First Line of Therapy!

Presenter: Jose Armando Mangione

REGISTER for free or LOG IN to view this content

Debate Con: TAVR for Moderate-Risk Patients: SAVR Remains First Line of Therapy!

We Recommend